Table of Contents
Advances in Psychiatry
Volume 2014, Article ID 365283, 16 pages
http://dx.doi.org/10.1155/2014/365283
Review Article

Early Detection and Treatment of Psychosis: The Bern Child and Adolescent Psychiatric Perspective

University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bolligenstrasse 111, Haus A, 3000 Bern 60, Switzerland

Received 26 June 2014; Revised 25 August 2014; Accepted 28 August 2014; Published 9 September 2014

Academic Editor: Jane E. Boydell

Copyright © 2014 Frauke Schultze-Lutter and Benno G. Schimmelmann. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. M. Gore, P. J. N. Bloem, G. C. Patton et al., “Global burden of disease in young people aged 10-24 years: a systematic analysis,” The Lancet, vol. 377, no. 9783, pp. 2093–2102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Olesen and M. Leonardi, “The burden of brain diseases in Europe,” European Journal of Neurology, vol. 10, no. 5, pp. 471–477, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Perälä, J. Suvisaari, S. I. Saarni et al., “Lifetime prevalence of psychotic and bipolar I disorders in a general population,” Archives of General Psychiatry, vol. 64, no. 1, pp. 19–28, 2007. View at Google Scholar
  4. J. B. Kirkbride, P. Fearon, C. Morgan et al., “Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center ÆSOP study,” Archives of General Psychiatry, vol. 63, no. 3, pp. 250–258, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. B. Kirkbride, C. Stubbins, and P. B. Jones, “Psychosis incidence through the prism of early intervention services,” The British Journal of Psychiatry, vol. 200, no. 2, pp. 156–157, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. B. G. Schimmelmann, S. J. Schmidt, M. Carbon, and C. U. Correll, “Treatment of adolescents with early-onset schizophrenia spectrum disorders: in search of a rational, evidence-informed approach,” Current Opinion in Psychiatry, vol. 26, no. 2, pp. 219–230, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. H. U. Wittchen, F. Jacobi, J. Rehm et al., “The size and burden of mental disorders and other disorders of the brain in Europe 2010,” European Neuropsychopharmacology, vol. 21, no. 9, pp. 655–679, 2011. View at Publisher · View at Google Scholar · View at MathSciNet
  8. A. Gustavsson, M. Svensson, F. Jacobi et al., “Cost of disorders of the brain in Europe 2010,” European Neuropsychopharmacology, vol. 21, no. 10, pp. 718–779, 2011. View at Google Scholar
  9. N. Charrier, K. Chevreul, and I. Durand-Zaleski, “The cost of schizophrenia: a literature review,” Encephale, vol. 39, supplement 1, pp. S49–S56, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Marshall, S. Lewis, A. Lockwood, R. Drake, P. Jones, and T. Croudace, “Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review,” Archives of General Psychiatry, vol. 62, no. 9, pp. 975–983, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. S. Keshavan, G. Haas, J. Miewald et al., “Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses,” Schizophrenia Bulletin, vol. 29, no. 4, pp. 757–769, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Köhn, A. Niedersteberg, A. Wieneke et al., “Frühverlauf schizophrener Ersterkrankungen mit langer Dauer der unbehandelten Erkrankung—eine vergleichende Studie,” Fortschr Neurol Psychiatr, vol. 72, no. 2, pp. 88–92, 2004. View at Google Scholar
  13. N. Schaffner, B. G. Schimmelmann, A. Niedersteberg, and F. Schultze-Lutter, “Versorgungswege von erstmanifesten psychotischen Patienten—eine Übersicht internationaler Studien,” Fortschr Neurol Psychiatr, vol. 80, no. 2, pp. 72–78, 2012. View at Publisher · View at Google Scholar
  14. D. Köhn, R. Pukrop, A. Niedersteberg et al., “Wege in die Behandlung: Hilfesuchverhalten schizophrener Ersterkrankter,” Fortschr Neurol Psychiatr, vol. 72, no. 11, pp. 635–642, 2004. View at Google Scholar
  15. H. G. von Reventlow, S. Krüger-Özgürdal, S. Ruhrmann et al., “Pathways to care in subjects at high risk for psychotic disorders—a European perspective,” Schizophrenia Research, vol. 152, no. 2-3, pp. 400–407, 2014. View at Google Scholar
  16. H. Hafner, B. Nowotny, W. Löffler, W. an der Heiden, and K. Maurer, “When and how does schizophrenia produce social deficits?” European Archives of Psychiatry and Clinical Neuroscience, vol. 246, no. 1, pp. 17–28, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Schultze-Lutter, S. Ruhrmann, J. Berning, W. Maier, and J. Klosterkötter, “Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state,” Schizophrenia Bulletin, vol. 36, no. 1, pp. 182–191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. T. H. McGlashan and J. O. Johannessen, “Early detection and intervention with schizophrenia: rationale,” Schizophrenia Bulletin, vol. 22, no. 2, pp. 201–222, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. P. D. McGorry, “‘A stitch in time’... the scope for preventive strategies in early psychosis,” European Archives of Psychiatry and Clinical Neuroscience, vol. 248, no. 1, pp. 22–31, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Huber and G. Gross, “The concept of basic symptoms in schizophrenic and schizoaffective psychoses,” Recenti Progressi in Medicina, vol. 80, no. 12, pp. 646–652, 1989. View at Google Scholar · View at Scopus
  21. P. D. McGorry, J. Edwards, C. Mihalopoulos, S. M. Harrigan, and H. J. Jackson, “EPPIC: an evolving system of early detection and optimal management,” Schizophrenia Bulletin, vol. 22, no. 2, pp. 305–326, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Conus, S. Cotton, B. G. Schimmelmann, P. McGorry, and M. Lambert, “The First-episode Psychosis Outcome Study (FEPOS): pre-morbid and baseline characteristics of an epidemiological cohort of 661 first-episode psychosis patients,” Early Intervention in Psychiatry, vol. 1, no. 2, pp. 191–200, 2007. View at Google Scholar
  23. P. Conus, S. Cotton, B. G. Schimmelmann, P. D. McGorry, and M. Lambert, “Pretreatment and outcome correlates of sexual and physical trauma in an epidemiological cohort of first-episode psychosis patients,” Schizophrenia Bulletin, vol. 36, no. 6, pp. 1105–1114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. M. Cotton, M. Lambert, B. G. Schimmelmann et al., “Differences between first episode schizophrenia and schizoaffective disorder,” Schizophrenia Research, vol. 147, no. 1, pp. 169–174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. S. M. Cotton, M. Lambert, B. G. Schimmelmann et al., “Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis,” Schizophrenia Research, vol. 114, no. 1–3, pp. 17–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. M. Cotton, M. Lambert, B. G. Schimmelmann et al., “Depressive symptoms in first episode schizophrenia spectrum disorder,” Schizophrenia Research, vol. 134, no. 1, pp. 20–26, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Lambert, P. Conus, B. G. Schimmelmann et al., “Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study,” Pharmacopsychiatry, vol. 38, no. 5, pp. 206–213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. K. K. Morley, S. M. Cotton, P. Conus et al., “Familial psychopathology in the first episode psychosis outcome study,” Australian and New Zealand Journal of Psychiatry, vol. 42, no. 7, pp. 617–626, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Rebgetz, P. Conus, L. Hides et al., “Predictors of substance use reduction in an epidemiological first-episode psychosis cohort,” Early Intervention in Psychiatry, vol. 24, pp. 1–24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Robinson, S. Cotton, P. Conus, B. G. Schimmelmann, P. McGorry, and M. Lambert, “Prevalence and predictors of suicide attempt in an incidence cohort of 661 young people with first-episode psychosis,” Australian and New Zealand Journal of Psychiatry, vol. 43, no. 2, pp. 149–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. S. M. Cotton, M. Lambert, M. Berk et al., “Gender differences in first episode psychotic mania,” BMC Psychiatry, vol. 13, no. 1, article 82, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Schöttle, B. G. Schimmelmann, P. Conus et al., “Differentiating schizoaffective and bipolar I disorder in first-episode psychotic mania,” Schizophrenia Research, vol. 140, no. 1–3, pp. 31–36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. B. G. Schimmelmann, P. Conus, J. Edwards, P. D. McGorry, and M. Lambert, “Diagnostic stability 18 months after treatment initiation for first-episode psychosis,” Journal of Clinical Psychiatry, vol. 66, no. 10, pp. 1239–1246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Lambert, P. Conus, D. I. Lubman et al., “The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis,” Acta Psychiatrica Scandinavica, vol. 112, no. 2, pp. 141–148, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. B. G. Schimmelmann, P. Conus, S. Cotton, S. Kupferschmid, P. D. McGorry, and M. Lambert, “Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis,” European Psychiatry, vol. 27, no. 6, pp. 463–469, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. B. G. Schimmelmann, P. Conus, S. M. Cotton et al., “Cannabis use disorder and age at onset of psychosis—a study in first-episode patients,” Schizophrenia Research, vol. 129, no. 1, pp. 52–56, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Conus, M. Lambert, S. Cotton, C. Bonsack, P. D. McGorry, and B. G. Schimmelmann, “Rate and predictors of service disengagement in an epidemiological first-episode psychosis cohort,” Schizophrenia Research, vol. 118, no. 1–3, pp. 256–263, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Lambert, P. Conus, S. Cotton, J. Robinson, P. D. McGorry, and B. G. Schimmelmann, “Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis,” Journal of Clinical Psychopharmacology, vol. 30, no. 5, pp. 565–572, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. B. G. Schimmelmann, P. Conus, M. Schacht, P. McGorry, and M. Lambert, “Predictors of service disengagement in first-admitted adolescents with psychosis,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 45, no. 8, pp. 990–999, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. B. G. Schimmelmann, P. Conus, S. Cotton, P. D. McGorry, and M. Lambert, “Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients,” Schizophrenia Research, vol. 95, no. 1–3, pp. 1–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. B. G. Schimmelmann, C. G. Huber, M. Lambert, S. Cotton, P. D. McGorry, and P. Conus, “Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort,” Journal of Psychiatric Research, vol. 42, no. 12, pp. 982–990, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Dragt, D. H. Nieman, F. Schultze-Lutter et al., “Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis,” Acta Psychiatrica Scandinavica, vol. 125, no. 1, pp. 45–53, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Lambert, A. Karow, S. Leucht, B. G. Schimmelmann, and D. Naber, “Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later,” Dialogues in Clinical Neuroscience, vol. 12, no. 3, pp. 393–407, 2010. View at Google Scholar · View at Scopus
  44. M. Lambert, D. Naber, A. Karow et al., “Subjective wellbeing under quetiapine treatment: Effect of diagnosis, mood state, and anxiety,” Schizophrenia Research, vol. 110, no. 1–3, pp. 72–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Lambert, D. Naber, A. Schacht et al., “Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia,” Acta Psychiatrica Scandinavica, vol. 118, no. 3, pp. 220–229, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Lambert, B. G. Schimmelmann, D. Naber et al., “Early- and delayed antipsychotic response and prediction of outcome in 528 severely impaired patients with schizophrenia treated with amisulpride,” Pharmacopsychiatry, vol. 42, no. 6, pp. 277–283, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Lambert, B. G. Schimmelmann, A. Schacht et al., “Long-term patterns of subjective wellbeing in schizophrenia: Cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years,” Schizophrenia Research, vol. 107, no. 2-3, pp. 165–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Lambert, D. Naber, F. X. Eich, M. Schacht, M. Linden, and B. G. Schimmelmann, “Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride,” Acta Psychiatrica Scandinavica, vol. 115, no. 2, pp. 106–113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Lambert, B. G. Schimmelmann, D. Naber et al., “Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia,” The Journal of Clinical Psychiatry, vol. 67, no. 11, pp. 1690–1697, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Meng, B. G. Schimmelmann, B. Mohler et al., “Pretreatment social functioning predicts 1-year outcome in early onset psychosis,” Acta Psychiatrica Scandinavica, vol. 114, no. 4, pp. 249–256, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. P. M. Wehmeier, M. Kluge, A. Schacht et al., “Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia,” Journal of Psychiatric Research, vol. 42, no. 8, pp. 676–683, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. B. G. Schimmelmann, C. Mehler-Wex, M. Lambert et al., “A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disorders,” Journal of Child and Adolescent Psychopharmacology, vol. 17, no. 6, pp. 768–778, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Karow, J. Czekalla, R. W. Dittmann et al., “Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia,” The Journal of Clinical Psychiatry, vol. 68, no. 1, pp. 75–80, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. B. G. Schimmelmann, S. Paulus, M. Schacht, C. Tilgner, M. Schulte-Markwort, and M. Lambert, “Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics,” Journal of Child and Adolescent Psychopharmacology, vol. 15, no. 2, pp. 249–258, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Lambert, T. Bock, A. Daubmann et al., “Integrierte Versorgung von Patienten mit psychotischen Erkrankungen nach dem Hamburger Modell: Teil 1,” Psychiatrische Praxis, vol. 41, no. 5, pp. 257–265, 2014. View at Google Scholar
  56. A. Karow, T. Bock, A. Daubmann et al., “Integrierte Versorgung von Patienten mit psychotischen Erkrankungen nach dem Hamburger Modell: Teil 2,” Psychiatrische Praxis, vol. 41, no. 5, pp. 266–273, 2014. View at Google Scholar
  57. D. Schöttle, A. Karow, B. G. Schimmelmann, and M. Lambert, “Integrated care in patients with schizophrenia: results of trials published between 2011 and 2013 focusing on effectiveness and efficiency,” Current Opinion in Psychiatry, vol. 26, no. 4, pp. 384–408, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Lambert, T. Bock, D. Schöttle et al., “Assertive community treatment as part of integrated care versus standard care: A 12-month trial in patients with first- and multiple-episode schizophrenia spectrum disorders treated with quetiapine immediate release (ACCESS trial),” Journal of Clinical Psychiatry, vol. 71, no. 10, pp. 1313–1323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Karow, J. Reimer, H. H. König et al., “Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial),” Journal of Clinical Psychiatry, vol. 73, no. 3, pp. e402–e408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Schöttle, B. G. Schimmelmann, and A. Karow, “Translating Research into clinical practice: effectiveness of integrated care including therapeutic assertive community treatment in severe schizophrenia-spectrum and bipolar I disorders—a 24-month follow-up study (ACCESS-II study),” Journal of Clinical Psychiatry. In press.
  61. F. Schultze-Lutter, “Prediction of psychosis is necessary and possible,” in Schizophrenia: Challenging the Orthodox, C. McDonald, K. Schultz, R. Murray, and P. Wright, Eds., pp. 81–90, Taylor & Francis, London, UK, 2004. View at Google Scholar
  62. E. Koch, F. Schultze-Lutter, B. G. Schimmelmann, and F. Resch, “On the importance and detection of prodromal symptoms from the perspective of child and adolescent psychiatry,” Clinical Neuropsychiatry, vol. 7, no. 2, pp. 38–48, 2010. View at Google Scholar · View at Scopus
  63. B. G. Schimmelmann, P. Walger, and F. Schultze-Lutter, “The significance of at-risk symptoms for psychosis in children and adolescents,” Canadian Journal of Psychiatry, vol. 58, no. 1, pp. 32–40, 2013. View at Google Scholar · View at Scopus
  64. B. G. Schimmelmann and F. Schultze-Lutter, “Early detection and intervention of psychosis in children and adolescents: urgent need for studies,” European Child and Adolescent Psychiatry, vol. 21, no. 5, pp. 239–241, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. F. Schultze-Lutter, F. Resch, E. Koch, and B. G. Schimmelmann, “Früherkennung von Psychosen bei Kindern und Adoleszenten—sind entwicklungsbezogene Besonderheiten ausreichend berücksichtigt?” Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, vol. 39, no. 5, pp. 301–311, 2011. View at Google Scholar
  66. E. Kraepelin, Psychiatrie. Ein Lehrbuch für Studierende und Ärzte. 8. vollständig umgearbeitete Auflage, Johann Ambrosius Barth, Leipzig, Germany, 1909.
  67. F. Schultze-Lutter, S. Ruhrmann, P. Fusar-Poli, A. Bechdolf, B. G. Schimmelmann, and J. Klosterkötter, “Basic symptoms and the prediction of first-episode psychosis,” Current Pharmaceutical Design, vol. 18, no. 4, pp. 351–357, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Conrad, Die beginnende Schizophrenie. Versuch einer Gestaltanalyse des Wahns, Thieme, Stuttgart, Germany, 1958.
  69. J. P. Docherty, D. P. Van Kammen, S. G. Siris, and S. R. Marder, “Stages of onset of schizophrenic psychosis,” The American Journal of Psychiatry, vol. 135, no. 4, pp. 420–426, 1978. View at Google Scholar · View at Scopus
  70. H. Häfner, K. Maurer, W. Löffler, W. An der Heiden, M. Hambrecht, and F. Schultze-Lutter, “Modeling the early course of schizophrenia,” Schizophrenia Bulletin, vol. 29, no. 2, pp. 325–340, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. F. Schultze-Lutter, “Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept,” Schizophrenia Bulletin, vol. 35, no. 1, pp. 5–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. A. R. Yung and P. O. McGorry, “The prodromal phase of first-episode psychosis: Past and current conceptualizations,” Schizophrenia Bulletin, vol. 22, no. 2, pp. 353–370, 1996. View at Publisher · View at Google Scholar · View at Scopus
  73. F. Schultze-Lutter, B. G. Schimmelmann, and S. Ruhrmann, “The near babylonian speech confusion in early detection of psychosis,” Schizophrenia Bulletin, vol. 37, no. 4, pp. 653–655, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. F. Schultze-Lutter, B. G. Schimmelmann, S. Ruhrmann, and C. Michel, “‘A rose is a rose is a rose’, but at-risk criteria differ,” Psychopathology, vol. 46, no. 2, pp. 75–87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. P. Fusar-Poli, S. Borgwardt, A. Bechdolf et al., “The psychosis high-risk state: a comprehensive state-of-the-art review,” JAMA Psychiatry, vol. 70, no. 1, pp. 107–120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. F. Schultze-Lutter, S. Ruhrmann, H. Picker, H. G. von Reventlow, A. Brockhaus-Dumke, and J. Klosterkötter, “Basic symptoms in early psychotic and depressive disorders,” British Journal of Psychiatry, vol. 191, supplement 51, pp. S31–S37, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. F. Schultze-Lutter, B. G. Schimmelmann, J. Klosterkötter, and S. Ruhrmann, “Comparing the prodrome of schizophrenia-spectrum psychoses and affective disorders with and without psychotic features,” Schizophrenia Research, vol. 138, no. 2-3, pp. 218–222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. W. Mayer-Gross, “Die klinik,” in Handbuch der Geisteskrankheiten—Spezieller Teil V: Die Schizophrenie, O. Bumke, Ed., Julius Springer, Berlin, Germany, 1932. View at Google Scholar
  79. G. Huber, “Reine Defektsyndrome und Basisstadien endogener Psychosen,” Fortschritte der Neurologie-Psychiatrie, vol. 34, pp. 409–426, 1966. View at Google Scholar
  80. J. Klosterkotter, H. Ebel, F. Schultze-Lutter, and E. M. Steinmeyer, “Diagnostic validity of basic symptoms,” European Archives of Psychiatry and Clinical Neuroscience, vol. 246, no. 3, pp. 147–154, 1996. View at Publisher · View at Google Scholar · View at Scopus
  81. F. Schultze-Lutter and J. Klosterkotter, “Do basic symptoms provide a possible explanation for the elevated risk for schizophrenia among mentally retarded?” Neurology Psychiatry and Brain Research, vol. 3, no. 1, pp. 29–34, 1995. View at Google Scholar · View at Scopus
  82. A. Bechdolf, F. Schultze-Lutter, and J. Klosterkötter, “Self-experienced vulnerability, prodromal symptoms and coping strategies preceding schizophrenic and depressive relapses,” European Psychiatry, vol. 17, no. 7, pp. 384–393, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. L. Süllwold and G. Huber, Schizophrene Basisstörungen, Springer, Berlin, Germany, 1986.
  84. G. Gross, G. Huber, J. Klosterkötter, and M. Linz, Bonner Skala für die Beurteilung von Basissymptomen (BSABS; Bonn Scale for the Assessment of Basic Symptoms), Springer, Berlin, Germany, 1987.
  85. J. Klosterkötter, G. Gross, G. Huber, A. Wieneke, E. M. Steinmeyer, and F. Schultze-Lutter, “Evaluation of the “bonn scale for the assessment of basic symptoms—BSABS” as an instrument for the assessment of schizophrenia proneness: a review of recent findings,” Neurology, Psychiatry and Brain Research, vol. 5, no. 3, pp. 137–150, 1997. View at Google Scholar · View at Scopus
  86. L. Süllwold, Manual Zum Frankfurter Beschwerde-Fragebogen (FBF), Springer, Berlin, Germany, 1991.
  87. R. Mass, K. Hitschfeld, E. Wall, and H. B. Wagner, “Validität der Erfassung schizophrener Basissymptome,” Nervenarzt, vol. 68, no. 3, pp. 205–211, 1997. View at Google Scholar
  88. F. Schultze-Lutter, E. M. Steinmeyer, S. Ruhrmann, and J. Klosterkötter, “The dimensional structure of self-reported prodromal disturbances in schizophrenia,” Clinical Neuropsychiatry, vol. 5, no. 3, pp. 140–150, 2008. View at Google Scholar · View at Scopus
  89. F. Schultze-Lutter, J. Addington, S. Ruhrmann, and J. Klosterkötter, Schizophrenia Proneness Instrument-Adult Version (SPI-A), Giovanni Fioriti Editore, Rome, Italy, 2007.
  90. F. Schultze-Lutter and E. Koch, Schizophrenia Proneness Instrument—Child and Youth Version (SPI-CY), Giovanni Fioriti Editore, Rome, Italy, 2010.
  91. F. Schultze-Lutter, M. Marshall, and E. Koch, Schizophrenia Proneness Instrument, Child and Youth Version, Extended English Translation (SPI-CY EET), Giovanni Fioriti Editore, Rome, Italy, 2012.
  92. L. Fux, P. Walger, B. G. Schimmelmann, and F. Schultze-Lutter, “The schizophrenia proneness instrument, child and youth version (SPI-CY): practicability and discriminative validity,” Schizophrenia Research, vol. 146, no. 1–3, pp. 69–78, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. F. Schultze-Lutter, S. Ruhrmann, and J. Klosterkötter, “Can schizophrenia be predicted phenomenologically?” in Evolving Psychosis. Different Stages, Different Treatments, J. O. Johannessen, B. Martindale, and J. Cullberg, Eds., pp. 104–123, Routledge, London, UK, 2010. View at Google Scholar
  94. M. Albers, F. Schultze-Lutter, E. M. Steinmeyer, and J. Klosterkötter, “Can self-experienced neuropsychological deficits indicate propensity to schizophrenic psychosis? Results of an 8-year prospective follow-up study,” International Clinical Psychopharmacology, vol. 13, supplement 1, pp. S75–S80, 1998. View at Publisher · View at Google Scholar · View at Scopus
  95. J. Klosterkötter, M. Hellmich, E. M. Steinmeyer, and F. Schultze-Lutter, “Diagnosing schizophrenia in the initial prodromal phase,” Archives of General Psychiatry, vol. 58, no. 2, pp. 158–164, 2001. View at Publisher · View at Google Scholar · View at Scopus
  96. F. Schultze-Lutter, “Ruling in or ruling out the schizophrenic prodrome: what criteria for symptom selection should be used?” Schizophrenia Research, vol. 41, no. 1, p. 179, 2000. View at Google Scholar
  97. F. Schultze-Lutter, J. Klosterkötter, H. Picker, E.-M. Steinmeyer, and S. Ruhrmann, “Predicting first-episode psychosis by basic symptom criteria,” Clinical Neuropsychiatry, vol. 4, no. 1, pp. 11–22, 2007. View at Google Scholar · View at Scopus
  98. A. Bechdolf, M. Wagner, S. Ruhrmann et al., “Preventing progression to first-episode psychosis in early initial prodromal states,” The British Journal of Psychiatry, vol. 200, no. 1, pp. 22–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Ruhrmann, F. Schultze-Lutter, R. K. R. Salokangas et al., “Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study,” Archives of General Psychiatry, vol. 67, no. 3, pp. 241–251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. F. Schultze-Lutter, J. Klosterkötter, and S. Ruhrmann, “Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms,” Schizophrenia Researc, vol. 154, no. 1–3, pp. 100–106, 2014. View at Google Scholar
  101. E. Velthorst, D. H. Nieman, H. E. Becker et al., “Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis,” Schizophrenia Research, vol. 109, no. 1–3, pp. 60–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. T. B. Ziermans, P. F. Schothorst, M. Sprong, and H. van Engeland, “Transition and remission in adolescents at ultra-high risk for psychosis,” Schizophrenia Research, vol. 126, no. 1–3, pp. 58–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. A. R. Yung, H. P. Yuen, G. Berger et al., “Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?” Schizophrenia Bulletin, vol. 33, no. 3, pp. 673–681, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. F. Schultze-Lutter, S. Ruhrmann, C. Hoyer, J. Klosterkötter, and F. M. Leweke, “The initial prodrome of schizophrenia: different duration, different underlying deficits?” Comprehensive Psychiatry, vol. 48, no. 5, pp. 479–488, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. F. Schultze-Lutter, S. Ruhrmann, and J. Klosterkötter, “Early detection of psychosis—establishing a service for persons at risk,” European Psychiatry, vol. 24, no. 1, pp. 1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. F. Schultze-Lutter, S. Ruhrmann, and J. Klosterkötter, “Early detection and early intervention in psychosis in Western Europe,” Clinical Neuropsychiatry, vol. 5, no. 6, pp. 303–315, 2008. View at Google Scholar
  107. H. Häfner, K. Maurer, S. Ruhrmann et al., “Early detection and secondary prevention of psychosis: facts and visions,” European Archives of Psychiatry and Clinical Neuroscience, vol. 254, no. 2, pp. 117–128, 2004. View at Google Scholar
  108. J. Klosterkötter, “The clinical staging and the endophenotype approach as an integrative future perspective for psychiatry,” World Psychiatry, vol. 7, no. 3, pp. 159–160, 2008. View at Google Scholar · View at Scopus
  109. J. Klosterkötter, F. Schultze-Lutter, and S. Ruhrmann, “Prediction and prevention of schizophrenia: what has been achieved and where to go next?” World Psychiatry, vol. 10, no. 3, pp. 165–174, 2011. View at Google Scholar · View at Scopus
  110. S. Ruhrmann, F. Schultze-Lutter, and J. Klosterkötter, “Early detection and intervention in the initial prodromal phase of schizophrenia,” Pharmacopsychiatry, vol. 36, supplement 3, pp. S162–S167, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. J. Klosterkötter, F. Schultze-Lutter, and S. Ruhrmann, “Kraepelin and psychotic prodromal conditions,” European Archives of Psychiatry and Clinical Neuroscience, vol. 258, no. 2, pp. 74–84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. S. Ruhrann, F. Schultze-Lutter, and J. Klosterkötter, “Sub-threshold states of psychosis—a challenge to diagnosis and treatment,” Clinical Neuropsychiatry, vol. 7, no. 2, pp. 72–87, 2010. View at Google Scholar · View at Scopus
  113. J. T. Bigger Jr., C. A. Heller, T. L. Wenger, and F. M. Weld, “Risk stratification after acute myocardial infarction,” The American Journal of Cardiology, vol. 42, no. 2, pp. 202–210, 1978. View at Publisher · View at Google Scholar · View at Scopus
  114. J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter et al., “The European prediction of psychosis study (EPOS): integrating early recognition and intervention in Europe,” World Psychiatry, vol. 4, no. 3, pp. 161–167, 2005. View at Google Scholar
  115. T. H. McGlashan, B. C. Walsh, and S. W. Woods, The Psychosis-Risk Syndrome, Oxford University Press, New York, NY, USA, 2010.
  116. R. K. R. Salokangas, S. Ruhrmann, H. G. von Reventlow et al., “Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries,” Schizophrenia Research, vol. 138, no. 2-3, pp. 192–197, 2012. View at Publisher · View at Google Scholar · View at Scopus
  117. D. H. Nieman, E. Velthorst, H. E. Becker et al., “The Strauss and Carpenter Prognostic Scale in subjects clinically at high risk of psychosis,” Acta Psychiatrica Scandinavica, vol. 127, no. 1, pp. 53–61, 2013. View at Publisher · View at Google Scholar · View at Scopus
  118. R. K. R. Salokangas, P. Dingemans, M. Heinimaa et al., “Prediction of psychosis in clinical high-risk patients by the Schizotypal Personality Questionnaire. Results of the EPOS project,” European Psychiatry, vol. 28, no. 8, pp. 469–475, 2013. View at Publisher · View at Google Scholar · View at Scopus
  119. F. Schultze-Lutter, J. Klosterkötter, C. Michel, K. Winkler, and S. Ruhrmann, “Personality disorders and accentuations in at-risk persons with and without conversion to first-episode psychosis,” Early Intervention in Psychiatry, vol. 6, no. 4, pp. 389–398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  120. F. Schultze-Lutter, J. Klosterkötter, A. Nikolaides, and S. Ruhrmann, “Personality dimensions in subjects symptomatically at-risk of psychosis: pronounced but lacking a characteristic profile,” Early Intervention in Psychiatry, 2014. View at Publisher · View at Google Scholar
  121. R. Pukrop, F. Schultze-Lutter, S. Ruhrmann et al., “Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia,” Journal of Clinical and Experimental Neuropsychology, vol. 28, no. 8, pp. 1388–1407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  122. E. Gouzoulis-Mayfrank, M. Balke, S. Hajsamou et al., “Orienting of attention in unmedicated patients with schizophrenia, prodromal subjects and healthy relatives,” Schizophrenia Research, vol. 97, no. 1–3, pp. 35–42, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. D. Koethe, C. W. Gerth, M. A. Neatby et al., “Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness,” Schizophrenia Research, vol. 88, no. 1–3, pp. 142–150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. D. Koethe, L. Kranaster, C. Hoyer et al., “Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophrenia,” European Archives of Psychiatry and Clinical Neuroscience, vol. 259, no. 4, pp. 195–202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  125. F. Schultze-Lutter, S. Ruhrmann, H. Picker et al., “Relationship between subjective and objective cognitive function in the early and late prodrome,” The British Journal of Psychiatry, vol. 191, supplement 51, pp. s43–s51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  126. R. Pukrop, S. Ruhrmann, F. Schultze-Lutter, A. Bechdolf, A. Brockhaus-Dumke, and J. Klosterkötter, “Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis,” Schizophrenia Research, vol. 92, no. 1–3, pp. 116–125, 2007. View at Publisher · View at Google Scholar · View at Scopus
  127. C. Michel, S. Ruhrmann, B. G. Schimmelmann, J. Klosterkötter, and F. Schultze-Lutter, “A stratified model for psychosis prediction in clinical practice,” Schizophrenia Bulletin, 2014. View at Publisher · View at Google Scholar
  128. A. Brockhaus-Dumke, I. Tendolkar, R. Pukrop, F. Schultze-Lutter, J. Klosterkötter, and S. Ruhrmann, “Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia,” Schizophrenia Research, vol. 73, no. 2-3, pp. 297–310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  129. A. Brockhaus-Dumke, F. Schultze-Lutter, R. Mueller et al., “Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode and chronic patients,” Biological Psychiatry, vol. 64, no. 5, pp. 376–384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. M. J. van Tricht, S. Ruhrmann, M. Arns et al., “Can quantitative EEG measures predict clinical outcome in subjects at clinical high risk for psychosis? A prospective multicenter study,” Schizophrenia Research, vol. 153, no. 1–3, pp. 42–47, 2014. View at Publisher · View at Google Scholar
  131. M. Bodatsch, S. Ruhrmann, M. Wagner et al., “Prediction of psychosis by mismatch negativity,” Biological Psychiatry, vol. 69, no. 10, pp. 959–966, 2011. View at Publisher · View at Google Scholar · View at Scopus
  132. J. T. Huang, F. M. Leweke, T. M. Tsang et al., “CSF metabolic and proteomic profiles in patients prodromal for psychosis,” PLoS ONE, vol. 2, no. 8, article e756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  133. D. Koethe, A. Giuffrida, D. Schreiber et al., “Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis,” British Journal of Psychiatry, vol. 194, no. 4, pp. 371–372, 2009. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Bechdolf, R. Pukrop, D. Köhn et al., “Subjective quality of life in subjects at risk for a first episode of psychosis: a comparison with first episode schizophrenia patients and healthy controls,” Schizophrenia Research, vol. 79, no. 1, pp. 137–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  135. S. Ruhrmann, J. Paruch, A. Bechdolf et al., “Reduced subjective quality of life in persons at risk for psychosis,” Acta Psychiatrica Scandinavica, vol. 117, no. 5, pp. 357–368, 2008. View at Publisher · View at Google Scholar · View at Scopus
  136. E. Velthorst, D. H. Nieman, D. Linszen et al., “Disability in people clinically at high risk of psychosis,” The British Journal of Psychiatry, vol. 197, no. 4, pp. 278–284, 2010. View at Publisher · View at Google Scholar · View at Scopus
  137. R. K. R. Salokangas, M. Heinimaa, T. From et al., “Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project,” European Psychiatry, vol. 29, no. 6, pp. 371–380, 2014. View at Google Scholar
  138. R. K. R. Salokangas, D. H. Nieman, M. Heinimaa et al., “Psychosocial outcome in patients at clinical high risk of psychosis: a prospective follow-up,” Social Psychiatry and Psychiatric Epidemiology, vol. 48, no. 2, pp. 303–311, 2013. View at Publisher · View at Google Scholar · View at Scopus
  139. F. Schultze-Lutter, H. Picker, S. Ruhrmann, and J. Klosterkötter, “Das Kölner Früh-Erkennungs- & Therapie-Zentrum für psychische Krisen (FETZ),” Medizinische Klinik, vol. 103, no. 2, pp. 81–89, 2008. View at Google Scholar
  140. S. J. Schmidt, V. M. Grunert, B. G. Schimmelmann, F. Schultze-Lutter, and C. Michel, “Differences in coping, self-efficacy, and external control beliefs between patients at-risk for psychosis and patients with first-episode psychosis,” Psychiatry Research, vol. 219, no. 1, pp. 95–102, 2014. View at Google Scholar
  141. F. Schultze-Lutter and S. Ruhrmann, Früherkennung und Frühbehandlung von Psychosen, Uni-Med, Bremen, Germany, 2008.
  142. A. Grispini and F. Schultze-Lutter, “Introductory remarks to special issue: early detection and intervention in psychosis around the world,” Clinical Neuropsychiatry, vol. 5, no. 5, article 261, 2008. View at Google Scholar
  143. S. W. Woods, J. Addington, K. S. Cadenhead et al., “Validity of the prodromal risk syndrome for first psychosis: findings from the north american prodrome longitudinal study,” Schizophrenia Bulletin, vol. 35, no. 5, pp. 894–908, 2009. View at Publisher · View at Google Scholar · View at Scopus
  144. S. Ruhrmann, F. Schultze-Lutter, and J. Klosterkötter, “Probably at-risk, but certainly ill—advocating the introduction of a psychosis spectrum disorder in DSM-V,” Schizophrenia Research, vol. 120, no. 1–3, pp. 23–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. W. T. Carpenter Jr., “Criticism of the DSM-V risk syndrome: a rebuttal,” Cognitive Neuropsychiatry, vol. 16, no. 2, pp. 101–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  146. F. Schultze-Lutter and B. G. Schimmelmann, “Psychotische Störungen im DSM-5,” Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, vol. 42, no. 3, pp. 193–202, 2014. View at Google Scholar
  147. A. R. Yung, S. W. Woods, S. Ruhrmann et al., “Whither the attenuated psychosis syndrome?” Schizophrenia Bulletin, vol. 38, no. 6, pp. 1130–1134, 2012. View at Google Scholar
  148. F. Schultze-Lutter, F. Renner, J. Paruch, D. Julkowski, J. Klosterkötter, and S. Ruhrmann, “Self-reported psychotic-like experiences are a poor estimate of clinician-rated attenuated and frank delusions and hallucinations,” Psychopathology, vol. 47, no. 3, pp. 194–201, 2014. View at Google Scholar
  149. C. Michel, B. G. Schimmelmann, S. Kupferschmid, M. Siegwart, and F. Schultze-Lutter, “Reliability of telephone assessments of at-risk criteria of psychosis: a comparison to face-to-face interviews,” Schizophrenia Research, vol. 153, no. 1–3, pp. 251–253, 2014. View at Publisher · View at Google Scholar
  150. F. Schultze-Lutter, C. Michel, S. Ruhrmann, and B. G. Schimmelmann, “Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the bern epidemiological at-risk (BEAR) study,” Schizophr Bull, 2013. View at Publisher · View at Google Scholar
  151. B. G. Schimmelmann, C. Michel, N. Schaffner, and F. Schultze-Lutter, “What percentage of people in the general population satisfies the current clinical at-risk criteria of psychosis?” Schizophrenia Research, vol. 125, no. 1, pp. 99–100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  152. I. Kelleher, H. Keeley, P. Corcoran et al., “Clinicopathological significance of psychotic experiences in non-psychotic young people: evidence from four population-based studies,” The British Journal of Psychiatry, vol. 201, no. 1, pp. 26–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  153. H. Meng, B. G. Schimmelmann, E. Koch et al., “Basic symptoms in the general population and in psychotic and non-psychotic psychiatric adolescents,” Schizophrenia Research, vol. 111, no. 1–3, pp. 32–38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  154. A. R. Yung, E. Killackey, S. E. Hetrick et al., “The prevention of schizophrenia,” International Review of Psychiatry, vol. 19, no. 6, pp. 633–646, 2007. View at Publisher · View at Google Scholar · View at Scopus
  155. S. Ruhrmann, J. Klosterkötter, M. Bodatsch et al., “Chances and risks of predicting psychosis,” European Archives of Psychiatry and Clinical Neuroscience, vol. 262, supplement 2, pp. 85–90, 2012. View at Publisher · View at Google Scholar
  156. J. Klosterkötter and F. Schultze-Lutter, “Prevention and early treatment,” in Ethics in Psychiatry—European Contributions, H. Helmchen and N. Sartorius, Eds., pp. 235–262, Springer Science+Business Media B.V., Heidelberg, The Netherlands, 2010. View at Google Scholar
  157. S. Ruhrmann, F. Schultze-Lutter, and J. Klosterkötter, “Intervention in the at-risk state to prevent transition to psychosis,” Current Opinion in Psychiatry, vol. 22, no. 2, pp. 177–183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  158. S. Ruhrmann, J. Klosterkötter, M. Bodatsch et al., “Pharmacological prevention and treatment in clinical at-risk states for psychosis,” Current Pharmaceutical Design, vol. 18, no. 4, pp. 550–557, 2012. View at Google Scholar
  159. M. van der Gaag, F. Smit, A. Bechdolf et al., “Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12month and longer-term follow-ups,” Schizophrenia Research, vol. 149, no. 1–3, pp. 56–62, 2013. View at Publisher · View at Google Scholar · View at Scopus
  160. F. Schultze-Lutter, Früherkennung der Schizophrenie anhand subjektiver Beschwerdeschilderungen: ein methodenkritischer Vergleich der Vorhersageleistung nonparametrischer statistischer und alternativer Verfahren zur Generierung von Vorhersagemodelle [dissertation], Philosophical Faculty of the University of Cologne, 2001.
  161. S. J. Schmidt and B. G. Schimmelmann, “Evidence-based psychotherapy in children and adolescents: advances, methodological and conceptual limitations, and perspectives,” European Child & Adolescent Psychiatry, vol. 22, no. 5, pp. 265–268, 2013. View at Publisher · View at Google Scholar · View at Scopus
  162. B. G. Schimmelmann, “Früherkennung von Psychosen Risiken und Nutzen bei Kindern und Jugendlichen abwägen,” Zeitschrift für Kinder und Jugendpsychiatrie und Psychotherapie, vol. 39, no. 5, pp. 297–299, 2011. View at Google Scholar
  163. L. Tarokh, C. Hamann, and B. G. Schimmelmann, “Sleep in child and adolescent psychiatry: overlooked and underappreciated,” European Child & Adolescent Psychiatry, vol. 23, no. 6, pp. 369–372, 2014. View at Google Scholar
  164. F. Schultze-Lutter, “Früherkennung von psychosen vor deren erstmanifestation: chance oder sackgasse? Die kerbe,” Forum für Sozialpsychiatrie, vol. 3, pp. 36–39, 2014. View at Google Scholar